Profound Medical Corp
PROF
$5.68-6.58%
End of day · as of Oct 8, 2026, 8:00 AM ET
Mkt cap
$238.74M
EV/Sales
11.4
P/E ratio
N/A
FY2025 Revenue
$16.10M
EPS (H1 2026)
$-0.46
Gross Margin (FY2025)
70.77%
Profit Margin (FY2025)
-264.44%
Beta
N/A
Div yield
N/A
Sector
Healthcare
No recent filings in cache.
Profound Medical Corp (PROF) is a medical devices company listed on NASDAQ.
Latest reported PROF revenue for 2025-12-31 was $16.1M. Net income was -$42.6M. Revenue was up 50.7% from 2024-12-31 to 2025-12-31. PROF currently screens at market cap $238.7M.
Use this PROF research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full PROF income, balance, and cash tables.
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
Profound Medical Corp (PROF) is a medical devices company in the Healthcare sector.
Latest cached Profound Medical Corp (PROF) revenue for Dec 31, 2025 was $16.1M. Net income was -$42.6M. Statements: https://lician.com/financials/prof
Profound Medical Corp (PROF) market capitalization is $238.7M on the latest cached snapshot.
Profound Medical Corp (PROF) cached previous close $6.08; day range $5.65 – $6.11; volume 196,269. Session quote: https://lician.com/quote/prof
Profound Medical Corp (PROF) latest cached earnings event is "PROF earnings" on Aug 13, 2026. Earnings calendar: https://lician.com/earnings